SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
14557751
Source:
http://linkedlifedata.com/resource/pubmed/id/14557751
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0010592
,
umls-concept:C0015264
,
umls-concept:C0034693
,
umls-concept:C0034721
,
umls-concept:C0045093
,
umls-concept:C0085149
,
umls-concept:C0205263
,
umls-concept:C1280500
,
umls-concept:C1704410
pubmed:issue
7
pubmed:dateCreated
2003-10-14
pubmed:abstractText
This study investigated the effect of the antineoplastic agent gemcitabine (dFdC) in combination with cyclosporine (CsA) or with FK506 on acute heart allograft rejection in a rat model.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0132144
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine
,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Isoantigens
,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus
,
http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0041-1337
pubmed:author
pubmed-author:HittmairAntonA
,
pubmed-author:JeskeHans-ChristianHC
,
pubmed-author:KlimaGüntherG
,
pubmed-author:MargreiterRaimundR
,
pubmed-author:OberladstätterJürgenJ
,
pubmed-author:ObristPeterP
,
pubmed-author:OllingerRobertR
,
pubmed-author:RobertsKurtK
,
pubmed-author:SchneebergerStefanS
,
pubmed-author:SchubertHeinrichH
,
pubmed-author:SteurerWolfgangW
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1046-52
pubmed:meshHeading
pubmed-meshheading:14557751-Acute Disease
,
pubmed-meshheading:14557751-Animals
,
pubmed-meshheading:14557751-Cyclosporine
,
pubmed-meshheading:14557751-Deoxycytidine
,
pubmed-meshheading:14557751-Drug Synergism
,
pubmed-meshheading:14557751-Graft Rejection
,
pubmed-meshheading:14557751-Graft Survival
,
pubmed-meshheading:14557751-Heart Transplantation
,
pubmed-meshheading:14557751-Immunosuppressive Agents
,
pubmed-meshheading:14557751-Isoantigens
,
pubmed-meshheading:14557751-Male
,
pubmed-meshheading:14557751-Rats
,
pubmed-meshheading:14557751-Rats, Inbred Lew
,
pubmed-meshheading:14557751-Tacrolimus
,
pubmed-meshheading:14557751-Tissue Donors
,
pubmed-meshheading:14557751-Transplantation Tolerance
pubmed:year
2003
pubmed:articleTitle
Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat.
pubmed:affiliation
Department of Transplant Surgery, D. Swarovski Research Laboratory, Innsbruck University Hospital, Innsbruck, Austria.
pubmed:publicationType
Journal Article